A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole as Monotherapy or as Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Aug 2018
At a glance
- Drugs Brexpiprazole (Primary) ; Sertraline
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 10 Aug 2018 Planned End Date changed from 1 Mar 2019 to 23 Nov 2018.
- 10 Aug 2018 Planned primary completion date changed from 1 Mar 2019 to 23 Nov 2018.
- 10 Aug 2018 Status changed from not yet recruiting to active, no longer recruiting.